Imatinib Mesylate Tablet, Film Coated
Product Images NDC 72485-202

4 FDA label images from Armas Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 72485-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig1)

Image Description (Fig1)
A Kaplan-Meier progression-free survival curve comparing Imatinib mesylate arm with IFN+Ara-C arm over 72 months since randomization. The y-axis represents the percentage without progression. The graph includes patient counts, hazard ratio, confidence interval, and statistical significance.*
FDA Label Image

Image Description (Fig2)

Image Description (Fig2)
A Kaplan-Meier curve titled 'Time to Progression to AP or BC (ITT Principle)' showing the percentage of patients without progression over 72 months since randomization. The chart compares Imatinib mesylate and IFN+Arc-C arms, with Imatinib showing higher progression-free percentage. Additional data include number of patients with progression or censored, hazard ratio, and statistical significance.*
FDA Label Image

Image Description (Imatinib Struc1.1)

Image Description (Imatinib Struc1.1)
Chemical structure of imatinib mesylate, showing its molecular framework including aromatic rings, nitrogen atoms, and a mesylate group.*
FDA Label Image

Image Description (Label1.3)

Image Description (Label1.3)
Label for Imatinib Mesylate Tablets 100 mg by Armas Pharmaceuticals Inc. The label indicates an oral film-coated tablet with 90 tablets per container. It includes storage instructions, manufacturer details (Shilpa Medicare Limited, India), distributor information (Armas Pharmaceuticals, USA), and a barcode. The label notes Rx Only status and emphasizes the 100 mg strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.